Banner - NPPA Connect
|Podcasts|December 14, 2022

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

In this episode, Christopher Bunick, MD, PhD, discusses a paper he recently co-authored, which explores JAK inhibitor safety compared to traditional systemic therapies for atopic dermatitis.


Latest CME